FDA-Inspected Site

Grifols Therapeutics LLC

17 FDA inspections are on record for Grifols Therapeutics LLC in Clayton, United States.

483· Form 483 issued

Clayton, United States · Last updated July 9, 2026

Overview

  • 17 FDA inspections are on record.
  • 10 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-05.

At a glance

Inspections

17

Form 483s

10

EIRs

2

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
28 Jan 2026 – 5 Feb 2026Biologics483View 483 →
28 Aug 2023 – 1 Sep 2023Biologics483On file
28 Apr 2022 – 6 May 2022Biologics483On file
5 Dec 2018 – 13 Dec 2018Biologics483On file
6 Feb 2017 – 10 Feb 2017Biologics483On file
12 Oct 2016 – 21 Oct 2016Biologics483On file
18 Mar 2014 – 1 Apr 2014Biologics483On file
13 Jan 2011Not recorded483On file
14 May 2010Not recorded483On file
5 Jun 2009Not recordedClean
24 Apr 2009Not recorded483On file
26 Jan 2007Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

5 Feb 2026
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Vijaya L Simhadri, Jennifer L Reed, Brentley S Pittman, Katarzyna I Jankowska

5 Feb 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Vijaya L Simhadri, Jennifer L Reed, Brentley S Pittman, Katarzyna I Jankowska

5 Feb 2026
21 CFR 600.80(c)(1)(i)

Reporting Requirements - 15-day alert

Cited by Vijaya L Simhadri, Jennifer L Reed, Brentley S Pittman, Katarzyna I Jankowska

Investigators

FDA investigators tied to this site in the record.

Katarzyna I Jankowska1 insp.
Kula N Jha1 insp.
Wei Wang1 insp.
Daniel C Kearns1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 600.80(c)(1)(i)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Grifols Therapeutics LLC's 10 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat